Technical Analysis for VNRX - VolitionRX Limited

Grade Last Price % Change Price Change
grade F 3.0 -0.99% -0.03
VNRX closed down 0.99 percent on Friday, May 22, 2020, on 1.71 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical VNRX trend table...

Date Alert Name Type % Chg
New Downtrend Bearish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
180 Bearish Setup Bearish Swing Setup -0.99%
NR7 Range Contraction -0.99%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


VolitionRX Limited, a development stage life sciences company, focuses on developing cancer detection blood tests for detecting and diagnosing cancer and other diseases. It develops two blood tests in the NuQ-X family to detect the presence of cancer by detecting nucleosomes containing specific nucleotides; and three blood tests in the NuQ-V family to detect cancer and nucleosomes containing specific histone variants. The company also develops nine blood tests in the NuQ-M family to detect cancer by detecting nucleosomes containing modified histones, the proteins that package, and order DNA into nucleosomes; and five blood tests in the NuQ-A family to detect cancer by detecting nucleosome-protein adducts, as well as offers research kits. It develops HyperGenomics tissue and blood-based tests to determine disease subtype following initial diagnosis and to help appropriate therapy; NuQ Endo endometriosis test; and NuQ clinical diagnostic products. VolitionRX Limited is based in Singapore.
Cancer Biology Diseases Disease Molecular Biology Epigenetics

Is VNRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 6.84
52 Week Low 2.22
Average Volume 214,576
200-Day Moving Average 4.43
50-Day Moving Average 3.56
20-Day Moving Average 3.87
10-Day Moving Average 3.57
Average True Range 0.30
ADX 26.09
+DI 13.21
-DI 33.04
Chandelier Exit (Long, 3 ATRs ) 3.58
Chandelier Exit (Short, 3 ATRs ) 3.69
Upper Bollinger Band 4.78
Lower Bollinger Band 2.96
Percent B (%b) 0.02
BandWidth 47.12
MACD Line -0.18
MACD Signal Line -0.03
MACD Histogram -0.1514
Fundamentals Value
Market Cap 79.55 Million
Num Shares 26.5 Million
EPS -0.52
Price-to-Earnings (P/E) Ratio -5.77
Price-to-Sales 0.00
Price-to-Book 3.88
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.33
Resistance 3 (R3) 3.35 3.27 3.28
Resistance 2 (R2) 3.27 3.18 3.26 3.26
Resistance 1 (R1) 3.13 3.13 3.09 3.11 3.24
Pivot Point 3.05 3.05 3.03 3.04 3.05
Support 1 (S1) 2.91 2.96 2.87 2.89 2.76
Support 2 (S2) 2.83 2.91 2.82 2.74
Support 3 (S3) 2.69 2.83 2.73
Support 4 (S4) 2.67